What happened

The White House has dropped President Donald Trump’s nomination of Heidi Overton to lead the US Food and Drug Administration, an administration official confirmed on Tuesday. The decision came before a scheduled vote on Wednesday in the Senate committee responsible for health. That vote would have decided whether the nomination advanced to the full Senate for confirmation.S1S3

Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, appeared before the Senate Committee on Health, Education, Labor and Pensions on 24 September. The committee’s public record identifies that session as her nomination hearing. It was the occasion for senators to question her, a separate stage from voting on whether to advance her nomination.R1S1S3

Why it matters

The committee has 21 members and Overton needed 11 votes to move forward, NBC reported. If all Democrats opposed her, the loss of even one Republican would have left her short. An administration official cited a lack of support in Congress in explaining the decision to Axios. There was no committee roll call showing how individual senators would have voted.S1S3S4

Bill Cassidy, the Republican chairman from Louisiana, had questioned whether Overton had enough experience managing an organisation to lead the regulator. He raised concerns publicly before the September hearing and said last week he remained undecided. Maine Republican Susan Collins also told NBC she wanted answers before taking a position. Overton has expressed support for restrictions on medication abortion, according to NBC’s account of her record.S1

The background

Alaska Republican Lisa Murkowski questioned Overton at the hearing about political pressure on access to mifepristone, a medication used in abortion. Murkowski criticised the clarity of the response but later declined to say how she would vote. The distinction matters in counting support: publicly questioning the nominee did not commit a senator to voting against her.S1

Overton previously served as chief policy officer at the America First Policy Institute. Her work at the White House on vaping policy also drew scrutiny, CBS reported. The FDA has been without a permanent commissioner since Marty Makary resigned in May. NBC reported that the administration’s decision on certain flavoured vaping products contributed to his departure.S1S4

What happens next

CBS cited sources who said the administration had already been speaking to potential candidates, including people who might serve in an acting capacity. That account concerned discussions about filling the vacancy. The White House official who confirmed the decision on Overton did not name a replacement in the accounts published on Tuesday.S1S3S4